![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CEP250 |
Gene summary for CEP250 |
![]() |
Gene information | Species | Human | Gene symbol | CEP250 | Gene ID | 11190 |
Gene name | centrosomal protein 250 | |
Gene Alias | C-NAP1 | |
Cytomap | 20q11.22 | |
Gene Type | protein-coding | GO ID | GO:0000226 | UniProtAcc | Q9BV73 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
11190 | CEP250 | LZE4T | Human | Esophagus | ESCC | 1.30e-10 | 2.90e-01 | 0.0811 |
11190 | CEP250 | LZE5T | Human | Esophagus | ESCC | 1.24e-02 | 5.30e-01 | 0.0514 |
11190 | CEP250 | LZE7T | Human | Esophagus | ESCC | 4.87e-08 | 3.91e-01 | 0.0667 |
11190 | CEP250 | LZE22T | Human | Esophagus | ESCC | 9.39e-03 | 2.99e-01 | 0.068 |
11190 | CEP250 | LZE24T | Human | Esophagus | ESCC | 4.37e-17 | 4.70e-01 | 0.0596 |
11190 | CEP250 | P1T-E | Human | Esophagus | ESCC | 4.52e-09 | 5.32e-01 | 0.0875 |
11190 | CEP250 | P2T-E | Human | Esophagus | ESCC | 5.42e-14 | 3.57e-01 | 0.1177 |
11190 | CEP250 | P4T-E | Human | Esophagus | ESCC | 3.60e-14 | 3.13e-01 | 0.1323 |
11190 | CEP250 | P5T-E | Human | Esophagus | ESCC | 1.58e-02 | 1.31e-01 | 0.1327 |
11190 | CEP250 | P8T-E | Human | Esophagus | ESCC | 3.93e-08 | 1.96e-01 | 0.0889 |
11190 | CEP250 | P9T-E | Human | Esophagus | ESCC | 2.28e-03 | 1.27e-01 | 0.1131 |
11190 | CEP250 | P10T-E | Human | Esophagus | ESCC | 1.59e-15 | 3.52e-01 | 0.116 |
11190 | CEP250 | P11T-E | Human | Esophagus | ESCC | 1.55e-04 | 2.99e-01 | 0.1426 |
11190 | CEP250 | P12T-E | Human | Esophagus | ESCC | 2.15e-21 | 4.39e-01 | 0.1122 |
11190 | CEP250 | P15T-E | Human | Esophagus | ESCC | 6.57e-12 | 3.32e-01 | 0.1149 |
11190 | CEP250 | P16T-E | Human | Esophagus | ESCC | 2.77e-19 | 3.57e-01 | 0.1153 |
11190 | CEP250 | P20T-E | Human | Esophagus | ESCC | 2.86e-08 | 2.71e-01 | 0.1124 |
11190 | CEP250 | P21T-E | Human | Esophagus | ESCC | 9.50e-18 | 4.15e-01 | 0.1617 |
11190 | CEP250 | P22T-E | Human | Esophagus | ESCC | 6.84e-12 | 2.86e-01 | 0.1236 |
11190 | CEP250 | P23T-E | Human | Esophagus | ESCC | 5.28e-13 | 3.02e-01 | 0.108 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:1903829111 | Esophagus | ESCC | positive regulation of cellular protein localization | 199/8552 | 276/18723 | 2.99e-19 | 3.45e-17 | 199 |
GO:000931419 | Esophagus | ESCC | response to radiation | 277/8552 | 456/18723 | 4.42e-11 | 1.43e-09 | 277 |
GO:00726985 | Esophagus | ESCC | protein localization to microtubule cytoskeleton | 43/8552 | 54/18723 | 3.28e-07 | 4.61e-06 | 43 |
GO:00443804 | Esophagus | ESCC | protein localization to cytoskeleton | 45/8552 | 58/18723 | 6.89e-07 | 8.99e-06 | 45 |
GO:00070982 | Esophagus | ESCC | centrosome cycle | 85/8552 | 130/18723 | 4.41e-06 | 4.69e-05 | 85 |
GO:00310233 | Esophagus | ESCC | microtubule organizing center organization | 92/8552 | 143/18723 | 5.04e-06 | 5.31e-05 | 92 |
GO:000941611 | Esophagus | ESCC | response to light stimulus | 183/8552 | 320/18723 | 2.03e-05 | 1.76e-04 | 183 |
GO:19055086 | Esophagus | ESCC | protein localization to microtubule organizing center | 28/8552 | 35/18723 | 3.40e-05 | 2.78e-04 | 28 |
GO:00715396 | Esophagus | ESCC | protein localization to centrosome | 26/8552 | 33/18723 | 1.06e-04 | 7.43e-04 | 26 |
GO:0010457 | Esophagus | ESCC | centriole-centriole cohesion | 12/8552 | 14/18723 | 2.51e-03 | 1.08e-02 | 12 |
GO:19055153 | Esophagus | ESCC | non-motile cilium assembly | 39/8552 | 61/18723 | 3.08e-03 | 1.28e-02 | 39 |
GO:190382922 | Liver | HCC | positive regulation of cellular protein localization | 199/7958 | 276/18723 | 1.15e-23 | 2.62e-21 | 199 |
GO:0031023 | Liver | HCC | microtubule organizing center organization | 82/7958 | 143/18723 | 2.38e-04 | 1.79e-03 | 82 |
GO:0007098 | Liver | HCC | centrosome cycle | 75/7958 | 130/18723 | 3.33e-04 | 2.34e-03 | 75 |
GO:00443802 | Liver | HCC | protein localization to cytoskeleton | 38/7958 | 58/18723 | 3.37e-04 | 2.36e-03 | 38 |
GO:007269811 | Liver | HCC | protein localization to microtubule cytoskeleton | 35/7958 | 54/18723 | 7.73e-04 | 4.65e-03 | 35 |
GO:00093146 | Liver | HCC | response to radiation | 223/7958 | 456/18723 | 3.08e-03 | 1.43e-02 | 223 |
GO:190550811 | Liver | HCC | protein localization to microtubule organizing center | 23/7958 | 35/18723 | 4.72e-03 | 2.02e-02 | 23 |
GO:007153911 | Liver | HCC | protein localization to centrosome | 21/7958 | 33/18723 | 1.16e-02 | 4.28e-02 | 21 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CEP250 | SNV | Missense_Mutation | c.2367G>T | p.Gln789His | p.Q789H | Q9BV73 | protein_coding | tolerated(0.12) | probably_damaging(0.998) | TCGA-EP-A2KB-01 | Liver | liver hepatocellular carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
CEP250 | SNV | Missense_Mutation | c.920N>G | p.Lys307Arg | p.K307R | Q9BV73 | protein_coding | tolerated(0.07) | benign(0.367) | TCGA-G3-A6UC-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD | |
CEP250 | SNV | Missense_Mutation | c.1893N>G | p.Ser631Arg | p.S631R | Q9BV73 | protein_coding | tolerated(0.3) | benign(0.01) | TCGA-UB-A7MB-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Targeted Molecular therapy | sorafenib | PD | |
CEP250 | SNV | Missense_Mutation | c.6332T>A | p.Leu2111Gln | p.L2111Q | Q9BV73 | protein_coding | deleterious(0.04) | possibly_damaging(0.509) | TCGA-05-4382-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
CEP250 | SNV | Missense_Mutation | c.4688N>T | p.Glu1563Val | p.E1563V | Q9BV73 | protein_coding | deleterious(0.01) | possibly_damaging(0.552) | TCGA-44-3918-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | carboplatin | SD | |
CEP250 | SNV | Missense_Mutation | c.5429G>C | p.Arg1810Thr | p.R1810T | Q9BV73 | protein_coding | tolerated(0.15) | possibly_damaging(0.496) | TCGA-49-6744-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | unknown | SD | |
CEP250 | SNV | Missense_Mutation | novel | c.6203N>T | p.Arg2068Met | p.R2068M | Q9BV73 | protein_coding | deleterious(0.02) | possibly_damaging(0.682) | TCGA-49-AARE-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
CEP250 | SNV | Missense_Mutation | c.2692N>G | p.Met898Val | p.M898V | Q9BV73 | protein_coding | tolerated(1) | benign(0) | TCGA-55-6983-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | chemo | CR | |
CEP250 | SNV | Missense_Mutation | novel | c.5527C>A | p.Leu1843Ile | p.L1843I | Q9BV73 | protein_coding | deleterious(0.03) | probably_damaging(0.997) | TCGA-55-7570-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
CEP250 | SNV | Missense_Mutation | c.5626G>T | p.Ala1876Ser | p.A1876S | Q9BV73 | protein_coding | tolerated(0.24) | benign(0.005) | TCGA-55-8094-01 | Lung | lung adenocarcinoma | Male | <65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |